We are live on ! Find out more
EHC icon

Encompass Health

387 hedge funds and large institutions have $6.05B invested in Encompass Health in 2018 Q2 according to their latest regulatory filings, with 67 funds opening new positions, 114 increasing their positions, 149 reducing their positions, and 29 closing their positions.

New
Increased
Maintained
Reduced
Closed

131% more first-time investments, than exits

New positions opened: 67 | Existing positions closed: 29

43% more call options, than puts

Call options by funds: $2.44M | Put options by funds: $1.71M

17% more funds holding in top 10

Funds holding in top 10: 67 (+1)

16% more capital invested

Capital invested by funds: $5.22B → $6.05B (+$829M)

9% more funds holding

Funds holding: 354387 (+33)

1.68% less ownership

Funds ownership: 117.4%115.73% (-1.7%)

23% less repeat investments, than reductions

Existing positions increased: 114 | Existing positions reduced: 149

Holders
387
Holders Change
+33
Holders Change %
+9.32%
% of All Funds
8.86%
Holding in Top 10
7
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+16.67%
% of All Funds
0.16%
New
67
Increased
114
Reduced
149
Closed
29
Calls
$2.44M
Puts
$1.71M
Net Calls
+$732K
Net Calls Change
-$2.41M
Name Holding Trade Value Shares
Change
Change in
Stake
CNBT
276
Canandaigua National Bank & Trust
New York
$372K -$50.5K -1,011 -13%
LCM
277
Laurion Capital Management
New York
$366K +$339K +6,790 New
SSA
278
Schonfeld Strategic Advisors
New York
$366K +$340K +6,800 New
VAM
279
Visionary Asset Management
Texas
$359K -$80.9K -1,619 -20%
OI
280
Oakbrook Investments
Illinois
$352K -$138K -2,766 -30%
DTL
281
Dynamic Technology Lab
Singapore
$345K -$121K -2,425 -27%
LTFS
282
Ladenburg Thalmann Financial Services
Florida
$336K
ZCA
283
Zeke Capital Advisors
Pennsylvania
$326K
Cambridge Investment Research Advisors
284
Cambridge Investment Research Advisors
Iowa
$301K +$9.64K +193 +4%
HFS
285
HL Financial Services
Kentucky
$297K
NIMI
286
Natixis Investment Managers International
France
$296K +$56.6K +1,133 +26%
HSBC Holdings
287
HSBC Holdings
United Kingdom
$292K -$1.11M -22,233 -80%
FRM
288
Fox Run Management
Connecticut
$283K +$263K +5,261 New
GCP
289
GSA Capital Partners
United Kingdom
$280K +$260K +5,193 New
MFWM
290
Motley Fool Wealth Management
Virginia
$279K -$14.7K -294 -5%
PTC
291
Petrus Trust Company
Texas
$276K -$37.7K -754 -13%
MCMT
292
Moon Capital Management (Tennessee)
Tennessee
$272K -$5K -100 -2%
FAM
293
Fred Alger Management
New York
$271K +$251K +5,028 New
DADC
294
D.A. Davidson & Co
Montana
$267K -$94.9K -1,899 -28%
JMPWA
295
JP Morgan Private Wealth Advisors
California
$261K +$242K +4,842 New
Koshinski Asset Management
296
Koshinski Asset Management
Illinois
$258K +$250 +5 +0.1%
MML Investors Services
297
MML Investors Services
Massachusetts
$258K +$239K +4,792 New
AG
298
Advisor Group
Arizona
$249K -$15.3K -306 -6%
Truist Financial
299
Truist Financial
North Carolina
$243K -$62.9K -1,259 -22%
CIBC Asset Management
300
CIBC Asset Management
Ontario, Canada
$237K +$220K +4,408 New

EHC Hedge Fund Activity: Q2 2018 in Review

387 of the 4,368 institutional investors tracked by Wall St. Rank reported a position in Encompass Health (EHC) for Q2 2018, worth a combined $6.05B — up 16% from $5.22B a quarter earlier.

Buyers outnumbered sellers: 67 funds opened new EHC positions and 29 closed out — a net gain of 38 holders — while 114 added to existing stakes and 149 trimmed.

The largest buyer was William Blair Investment Management, adding an estimated $58M. The largest seller was BlackRock, cutting an estimated $118M.

  • 387 institutional investors held Encompass Health (EHC) as of Q2 2018, up from 354 in Q1 2018.
  • Funds reported $6.05B of Encompass Health stock for Q2 2018, up 16% quarter-over-quarter.
  • 67 funds opened new Encompass Health positions in Q2 2018 and 29 closed out, a net change of +38 holders.
  • The largest Encompass Health buyer in Q2 2018 was William Blair Investment Management, an estimated $58M added.
  • The largest Encompass Health seller in Q2 2018 was BlackRock, an estimated $118M sold.

Based on aggregated 13F filings for Q2 2018.